Immunization

Researchers in Kenya explored vaccination behaviors among individuals of various socioeconomic or educational statuses.

Among pediatric patients in Colombia, researchers explored the prevalence of bacterial acute otitis media caused by Streptococcus pneumoniae.

The 2024-2025 updated COVID-19 vaccine containing the Omicron JN.1 lineage did not increase the risk of 29 adverse events of special interest.

Secretary of US Health and Human Services Robert F. Kennedy Jr also approved all recommendations issued from the April ACIP meeting.

Flu vaccination significantly reduces illness in vaccinated and unvaccinated individuals, highlighting its importance in public health strategies.

New study data reveal the waning effectiveness of 2023-2024 COVID-19 vaccines, highlighting the need for ongoing vaccinations and pharmacist involvement.

The new presentation of Shingrix will allow for easier administration.

New research findings reveal amoxicillin's effectiveness varies in treating invasive pneumococcal disease, highlighting the importance of patient-specific factors in antibiotic therapy.

Older adults are more likely to have chronic diseases, such as lung or heart disease, which makes them more susceptible to invasive pneumococcal disease.

Health care professionals emphasize patient education and reliable information in the evolving vaccine recommendation landscape.

Kevin W. Cleveland, PharmD, urges evidence-based approaches to immunizations in an era of uncertainty.

Cherokee Layson-Wolf, PharmD, BCACP, FAPhA, discusses the impact of shifting guidance on vaccination strategies.

As concerns mount over potential shifts in vaccine recommendations, Deanna Tran, PharmD, BCACP, FAPhA, advocates for rigorous data assessment and patient-centered communication strategies.

Of those who do not support vaccines, 79% said a major reason for their opposition is that it should be the parents’ choice about whether to vaccinate their child, and 40% cite safety concerns.

ACIP also discusses COVID-19 epidemiology as well as safety and efficacy for the COVID-19 vaccines.

Thimerosal is a mercury-containing compound that has been widely used as a preservative in some biological and drug products since the 1930s.

Kevin Cleveland, PharmD, discusses how pharmacists are uniquely positioned to directly interact with patients, making them vital in addressing vaccine misinformation.

Laura Knockel, PharmD, BCACP, expresses concerns about how vaccine recommendations are being communicated, noting a shift away from traditional, transparent discussions to less formal channels such as social media.

Cherokee Layson-Wolf, PharmD, BCACP, FAPhA, highlights the critical role pharmacists play in navigating vaccine recommendations and supporting patient understanding.

Deanna Tran, PharmD, BCACP, FAPhA, emphasizes community outreach, especially in areas with high vaccine hesitancy, as a crucial strategy for maintaining public trust in vaccination programs.

Researchers reviewed current understandings of the role vaccines play in dermatology, what gaps persist, and what future research is necessary.

Pharmacists stress that rebuilding trust is challenging and requires careful, empathetic communication.

Researchers conducted a systematic review and meta-analysis to estimate vaccine coverage and identify factors associated with vaccination among forcibly displaced, pediatric populations.

Noel Brewer, PhD, states that the Advisory Committee of Immunization Practices will need to quickly work to regain trust.

The conflicting information and abrupt changes are likely to contribute to a lack of trust and confidence in health care, Lauren Angelo, PharmD, MBA, said.